| KALA BIO INC. DL-,001 |
| USA |
| Gesundheit |
| US4831192020 / A3DWPS |
| 27F0 (Frankfurt) / KALA (NASDAQ) |
| FRA:27F0, ETR:27F0, 27F0:GR, NASDAQ:KALA |
| - |
| https://www.kalarx.com/ |
|
Kala Pharmaceuticals, Inc. is a biopharmaceutical ..
>Volltext.. |
| 6.84 Mio. EUR |
| 14.37 Mio. EUR |
| - |
| -35.62 Mio. EUR |
| -30.9 Mio. EUR |
| -5.12 EUR |
| 25.82 Mio. EUR |
| 18.19 Mio. EUR |
| -27.62 Mio. EUR |
| 0.65 |
| - |
| 12.72% |
| - |
| - |
| - |
| - |
| KALA BIO |
| 01.12.25 |